Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction

Eur J Pharmacol. 2008 Oct 10;594(1-3):77-83. doi: 10.1016/j.ejphar.2008.07.045. Epub 2008 Jul 31.

Abstract

Evidence that Rho-kinase is involved in cerebral infarction has accumulated. However, it is uncertain whether Rho-kinase is activated in the brain parenchyma in cerebral infarction. To answer this question, we measured Rho-kinase activity in the brain in a rat cerebral infarction model. Sodium laurate was injected into the left internal carotid artery, inducing cerebral infarction in the ipsilateral hemisphere. At 6 h after injection, increase of activating transcription factor 3 (ATF3) and c-Fos was found in the ipsilateral hemisphere, suggesting that neuronal damage occurs. At 0.5, 3, and 6 h after injection of laurate, Rho-kinase activity in extracts of the cerebral hemispheres was measured by an ELISA method. Rho-kinase activity in extracts of the ipsilateral hemisphere was significantly increased compared with that in extracts of the contralateral hemisphere at 3 and 6 h but not 0.5 h after injection of laurate. Next, localization of Rho-kinase activity was evaluated by immunohistochemical analysis in sections of cortex and hippocampus including infarct area 6 h after injection of laurate. Staining for phosphorylation of myosin-binding subunit (phospho-MBS) and myosin light chain (phospho-MLC), substrates of Rho-kinase, was elevated in neuron and blood vessel, respectively, in ipsilateral cerebral sections, compared with those in contralateral cerebral sections. These findings indicate that Rho-kinase is activated in neuronal and vascular cells in a rat cerebral infarction model, and suggest that Rho-kinase could be an important target in the treatment of cerebral infarction.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Activating Transcription Factor 3 / metabolism
  • Amides / pharmacology
  • Animals
  • Blotting, Western
  • Brain / enzymology*
  • Brain / pathology
  • Cerebral Cortex / enzymology
  • Cerebral Cortex / pathology
  • Cerebral Infarction / enzymology*
  • Cerebral Infarction / pathology
  • Enzyme Inhibitors / pharmacology
  • Hippocampus / enzymology
  • Hippocampus / pathology
  • Immunohistochemistry
  • Male
  • Myosin Light Chains / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-fos / metabolism
  • Proto-Oncogene Proteins c-jun / metabolism
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Extracts / chemistry
  • Tissue Extracts / metabolism
  • rho-Associated Kinases / antagonists & inhibitors
  • rho-Associated Kinases / metabolism*

Substances

  • Activating Transcription Factor 3
  • Amides
  • Atf3 protein, rat
  • Enzyme Inhibitors
  • Myosin Light Chains
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • Pyridines
  • Tissue Extracts
  • Y 27632
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • rho-Associated Kinases
  • fasudil